Literature DB >> 29876827

The significance of scirrhous gastric cancer cell lines: the molecular characterization using cell lines and mouse models.

Masakazu Yashiro1,2, Tasuku Matsuoka3, Masaichi Ohira3.   

Abstract

Scirrhous gastric cancer (SGC) exhibits aggressiveness of the rapid infiltrating tumor cells with abundant fibroblasts. Experimental studies using SGC cell lines have obtained useful information about this cancer. Our literature search divulged a total of 18 SGC cell lines; two cell lines were established from primary SGC and the other lines were established from a metastatic lesion of SGC. Fibroblast growth factor receptor 2 (FGFR2) and transforming growth factor-beta receptor (TβR) are linked to the rapid development of SGC. Cross-talk between the cancer cells and cancer-associated fibroblasts (CAFs) has been shown to contribute to the progression of SGC. Chemokine (C-X-C motif) receptor 1 (CXCR1) from SGC cells might be associated with the abundant CAFs in cancer microenvironments. The in vivo models established using SGC cell lines are expected to serve as a useful tool for the development of drugs such as FGFR2 inhibitors, TβR inhibitors, and CXCR1 inhibitors, which might be promising as SGC treatments. However, the number of available SGC cell lines is insufficient for the clarification of the entire biologic behavior of SGC. Since the mechanisms responsible for the characteristic aggressiveness of SGC are not fully elucidated, the establishment of new SGC cell lines could help clarify the biological behavior of SGC and contribute to its treatment.

Entities:  

Keywords:  Cell line; Characterization; Establishment; Mouse models; Scirrhous gastric cancer

Mesh:

Substances:

Year:  2018        PMID: 29876827     DOI: 10.1007/s13577-018-0211-4

Source DB:  PubMed          Journal:  Hum Cell        ISSN: 0914-7470            Impact factor:   4.174


  90 in total

1.  Proteomic differential display analysis shows up-regulation of 14-3-3 sigma protein in human scirrhous-type gastric carcinoma cells.

Authors:  Yasuhiro Kuramitsu; Byron Baron; Shigefumi Yoshino; Xiulian Zhang; Toshiyuki Tanaka; Masakazu Yashiro; Kosei Hirakawa; Masaaki Oka; Kazuyuki Nakamura
Journal:  Anticancer Res       Date:  2010-11       Impact factor: 2.480

2.  Establishment of a new scirrhous gastric cancer cell line with loss of heterozygosity at E-cadherin locus.

Authors:  K Murahashi; M Yashiro; C Takenaka; T Matsuoka; M Ohira; K H Chung
Journal:  Int J Oncol       Date:  2001-11       Impact factor: 5.650

3.  Role of ERas in promoting tumour-like properties in mouse embryonic stem cells.

Authors:  Kazutoshi Takahashi; Kaoru Mitsui; Shinya Yamanaka
Journal:  Nature       Date:  2003-05-29       Impact factor: 49.962

4.  [Establishment and characterization of a human scirrhus type gastric cancer cell line, GCIY, producing CA19-9].

Authors:  M Nozue; M Nishida; T Todoroki; Y Iwasaki
Journal:  Hum Cell       Date:  1991-03       Impact factor: 4.174

5.  Establishment and characterization of a human gastric scirrhous carcinoma cell line in serum-free chemically defined medium.

Authors:  K Yanagihara; N Kamada; M Tsumuraya; F Amano
Journal:  Int J Cancer       Date:  1993-05-08       Impact factor: 7.396

6.  Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012.

Authors:  Jacques Ferlay; Isabelle Soerjomataram; Rajesh Dikshit; Sultan Eser; Colin Mathers; Marise Rebelo; Donald Maxwell Parkin; David Forman; Freddie Bray
Journal:  Int J Cancer       Date:  2014-10-09       Impact factor: 7.396

7.  Expression of ERas oncogene in gastric carcinoma.

Authors:  Ryoji Kaizaki; Masakazu Yashiro; Osamu Shinto; Koichi Yasuda; Taro Matsuzaki; Tetsuji Sawada; Kosei Hirakawa
Journal:  Anticancer Res       Date:  2009-06       Impact factor: 2.480

8.  miR 1296-5p Inhibits the Migration and Invasion of Gastric Cancer Cells by Repressing ERBB2 Expression.

Authors:  Xia Shan; Wei Wen; Danxia Zhu; Ting Yan; Wenfang Cheng; Zebo Huang; Lan Zhang; Huo Zhang; Tongshan Wang; Wei Zhu; Yichao Zhu; Jun Zhu
Journal:  PLoS One       Date:  2017-01-18       Impact factor: 3.240

9.  MicroRNA-143 regulates collagen type III expression in stromal fibroblasts of scirrhous type gastric cancer.

Authors:  Yutaka Naito; Naoya Sakamoto; Naohide Oue; Masakazu Yashiro; Kazuhiro Sentani; Kazuyoshi Yanagihara; Kosei Hirakawa; Wataru Yasui
Journal:  Cancer Sci       Date:  2014-01-08       Impact factor: 6.716

10.  Stromal fibroblasts mediate extracellular matrix remodeling and invasion of scirrhous gastric carcinoma cells.

Authors:  Hideki Yamaguchi; Nachi Yoshida; Miho Takanashi; Yuumi Ito; Kiyoko Fukami; Kazuyoshi Yanagihara; Masakazu Yashiro; Ryuichi Sakai
Journal:  PLoS One       Date:  2014-01-10       Impact factor: 3.240

View more
  4 in total

1.  Multi-omic profiling of peritoneal metastases in gastric cancer identifies molecular subtypes and therapeutic vulnerabilities.

Authors:  Yosuke Tanaka; Fumiko Chiwaki; Shinya Kojima; Masahito Kawazu; Masayuki Komatsu; Toshihide Ueno; Satoshi Inoue; Shigeki Sekine; Keisuke Matsusaki; Hiromichi Matsushita; Narikazu Boku; Yae Kanai; Yasushi Yatabe; Hiroki Sasaki; Hiroyuki Mano
Journal:  Nat Cancer       Date:  2021-08-16

2.  Identification of candidates for driver oncogenes in scirrhous-type gastric cancer cell lines.

Authors:  Eirin Sai; Yoshiyuki Miwa; Reina Takeyama; Shinya Kojima; Toshihide Ueno; Masakazu Yashiro; Yasuyuki Seto; Hiroyuki Mano
Journal:  Cancer Sci       Date:  2019-07-15       Impact factor: 6.716

3.  SDF1α/CXCR4 axis may be associated with the malignant progression of gastric cancer in the hypoxic tumor microenvironment.

Authors:  Masakazu Yashiro; Haruhito Kinoshita; Gen Tsujio; Tatsunari Fukuoka; Yurie Yamamoto; Tomohiro Sera; Atsushi Sugimoto; Sadaaki Nishimura; Shuhei Kushiyama; Shingo Togano; Kenji Kuroda; Takahiro Toyokawa; Masaichi Ohira
Journal:  Oncol Lett       Date:  2020-11-12       Impact factor: 2.967

4.  Clinical difference between fibroblast growth factor receptor 2 subclass, type IIIb and type IIIc, in gastric cancer.

Authors:  Masakazu Yashiro; Kenji Kuroda; Go Masuda; Tomohisa Okuno; Yuichiro Miki; Yurie Yamamoto; Tomohiro Sera; Atsushi Sugimoto; Shuhei Kushiyama; Sadaaki Nishimura; Shingo Togano; Masaichi Ohira
Journal:  Sci Rep       Date:  2021-02-25       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.